DE7411543U - INHALER FOR POWDERED SUBSTANCES - Google Patents

INHALER FOR POWDERED SUBSTANCES

Info

Publication number
DE7411543U
DE7411543U DE7411543U DE7411543U DE7411543U DE 7411543 U DE7411543 U DE 7411543U DE 7411543 U DE7411543 U DE 7411543U DE 7411543 U DE7411543 U DE 7411543U DE 7411543 U DE7411543 U DE 7411543U
Authority
DE
Germany
Prior art keywords
inhaler
pump
capsule
perforating needle
locking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE7411543U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isf SpA Trezzano Sul Naviglio Mailand (italien)
Original Assignee
Isf SpA Trezzano Sul Naviglio Mailand (italien)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2257673A external-priority patent/IT986056B/en
Priority claimed from IT2569873A external-priority patent/IT1045851B/en
Application filed by Isf SpA Trezzano Sul Naviglio Mailand (italien) filed Critical Isf SpA Trezzano Sul Naviglio Mailand (italien)
Publication of DE7411543U publication Critical patent/DE7411543U/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Description

Dft. STE-H&» S. BESZEiJESDft. STE-H & »S. BESZEiJES

3 DAOHAU bsi MÜHCHEN3 DAOHAU to MÜHCHEN

Afci HcIDEVIEQ ?.
TELEPHON: DACHAU 43 71
Afci HcIDEVIEQ?.
TELEPHONE: DACHAU 43 71

P 6?IP 6? I

B e ω c b rB e ω c b r

zur Patentomieldungfor patent application

I.S.P. S.p.A. Trossano s/T.? (Hilano), ItalienI.S.P. Spa. Trossano s / T.? (Hilano), Italy

"betreffend"concerning

Inhalntor1 fib? pf:lvori*örnip;e Sv;batanaoaInhaler 1 fib? pf: lvori * örnip; e Sv; batanaoa

Die Erfindung betrifft einen Inhalator sur Yera'breis von pulverfönaigon Araneinittelno The invention relates to an inhaler sur Yera'breis from pulverfönaigon Araneinmittel o

IjS sind bereits Inhalatorea lator Vcrvxenclujig einer elastischen i'u'ape und einer !Tadel zun Durcb-Gtoßen einer eino Arzneimittolsubstrma enthaltenden Kapsel.bekannt. !21 all';cT;ioinon iat aber deren Arbaiten nicht völlig zufriedenstellend, ihre· Ausführung ziemlich, koapliüiex't und der Platzbedarf durch ihre Ab-nenr.vinsen ^roß.Inhaler reactors with an elastic tape and a reprimand for pushing a capsule containing a drug substrate are already known. ! 21 all '; c T ; ioinon iat but their work is not completely satisfactory, their execution fairly, koapliüiex't and the space required by their ab-nenr.vinsen ^ roß.

-

7411543 05.OZ767411543 05.OZ76

OH. CTEPHAN Q. BESZEDEb PATENTANWALT OH. CTEPHAN Q. BESZEDEb PATENT ADVOCATE

806 DACHAU bei MÖNCHEN806 DACHAU near MÖNCHEN

POSTFACH 1.68PO Box 1.68

AM HEIDEWEG 2AM HEIDEWEG 2

TELEPHON: DACHAU 43 71TELEPHONE: DACHAU 43 71 Postschsckkonto München (BLZ 700 100 80)Postschsckkonto Munich (bank code 700 100 80)

Konto-Nr. 136S 7tAccount no. 136S 7t

Bankkonto Nr. GO 637 bei der Kreis- und Stadtsparkasse Dacheil'iAdersdorf (BLZ 700 515 40)Bank account no.GO 637 at the Kreis- und Stadtsparkasse Dacheil'iAdersdorf (bank code 700 515 40)

22. Oktober 1975 G 74 115 43.8 P 672October 22, 1975 G 74 115 43.8 P 672

Die Bauteile 1 und 2 beziehungsweise 10 und 21 können als gegenüber den anderen Bestandteilen des Inhalators beweglich angesehen werden, wie es aus einem Vergleich der Figuren 1 und 4 hervorgeht.The components 1 and 2 or 10 and 2 1 can be viewed as movable with respect to the other components of the inhaler, as can be seen from a comparison of FIGS. 1 and 4.

Der Inhalator umfaßt ferner Anschlagmuffen 7i 7'» welche mit je einem inneren Anschlag 20, 20', von welchen jeder mit einem Anschlag 19 beziehungsweise 19' des jeweiligen Perforiernadelhalterelementes 2 beziehungsweise 2' zusammenwirkt, versehen sind, wie es insbesondere in Figur 1 dargestellt ist. Die Anschlagmuffen 7, 71 sind durch Verkleben oder durch Rändelungen, wie es in Figur 3 dargestellt ist, an die bei 17 aneinandergeschraubten Kapselhalterteile 3j 4, welche einen Hohlraum 8 zur Aufnahme der Kapsel 16 bilden, starr befestigt. Beide Kapselhalterteile 3» 4 haben je einen Durchtritt 18, 18', welche den Durchgang der Perforiernadeln 5, 51 und von Luft gestatten. Um die Perforiernadel 5, 5' von der Kapsel 16 getrennt zu halten, sind zwei Rückholfedern 21, 21' an den manteiförmigen Enden jedes Perforiernadelhalterelementes 2, 21 in je einem ringförmigen Hohlraum zur Aufnahme von zylindrischen Rückholfedern 21 beziehungsweise 21' zusammengedrückt angeordnet, so daß die Rückholfedern 21 beziehungsweise 21' zwischen dem Boden des Rückholfederhaltehohlraumes und den Enden der Verlängerung des Perforiernadelhalterelementes 2 beziehungsweise 21 arbeiten. 14 ist eine Aus-The inhaler further comprises stop sleeves 7i 7 '' which are each provided with an inner stop 20, 20 ', each of which interacts with a stop 19 or 19' of the respective perforating needle holder element 2 or 2 ', as shown in particular in FIG . The stop sleeves 7, 7 1 are rigidly attached by gluing or knurling, as shown in FIG. Both capsule holder parts 3 »4 each have a passage 18, 18 ', which allow the passage of the perforating needles 5, 5 1 and air. In order to keep the perforating needle 5, 5 'separated from the capsule 16, two return springs 21, 21' are arranged pressed together at the jacket-shaped ends of each perforating needle holder element 2, 2 1 in an annular cavity for receiving cylindrical return springs 21 and 21 ', respectively that the return springs 21 and 21 'work between the bottom of the return spring holding cavity and the ends of the extension of the perforating needle holder element 2 and 2 1 , respectively. 14 is an

7411543 05.01767411543 05.0176

Der Erfindung· liegt die Aufgabe zugrunde, einen über den angegebenen Stand der Technik vorbesserten Inhalator von einfacher Ausführung, rascher und sicherer Wirkung und verringerten Abmessungen zu schaffen.The invention · is based on the object of a Inhaler improved over the stated state of the art of simple execution, quick and safe operation and reduced dimensions.

Die Erfindung geht von einem Inhalator für in einer mittels einer Perforiernadel zu durchstoßenden Kapsel enthaltene pi/lvürföraige Substanzen, welche mit Hilfe einer Pumpe zu verteilen sind, mit eineia oberen Teil, an dessen EndQ die pulverförmige Substanz austritt, einem mittleren Teil und einem unteren Teil aum Anschließen an die Pumpe aus. Die oben angeführte Problemstellung wird hierbei dadurch gelöst, daß der Inhalator durch ein ortsfestes mittleres Element als mittleren Teil, das von zwei, vorzugsx<reise durch Verschrauben beziehungsweise eine Bajonettkupplung, miteinander zu verbindenden Kapselhalterteilen gebildet ist und einen Hohlraum zur Aufnahme der Kapsel aufweist, und zwei gegeneinander bewegliche Perforiernadelhalterelemente im oberen Teil beziehungsweise unteren Teil, welche in die beiden. Kapselhalterteile gegen die Wirkung von Rückholfedern teleskopartig hineinbewegbar sind, gekennzeichnet ist.The invention relates to an inhaler for contained in a capsule to be pierced by means of a perforating needle pi / lvüröraige substances, which with the help of a Pump are to be distributed, with an upper part on its EndQ the powdery substance emerges, a middle one Part and a lower part for connecting to the pump. The above-mentioned problem is thereby solved solved that the inhaler through a stationary middle element as the middle part, which of two, preferred x <travels is formed by screwing or a bayonet coupling to be connected to each other capsule holder parts and has a cavity for receiving the capsule, and two perforating needle holder elements which are movable relative to one another in the upper part and lower part, which in the two. Capsule holder parts against the action of return springs are telescopically movable in, is characterized.

Gemäß einer Ausgestaltung des Erfindungsgedankens ist es zweckmäßig, daß die beiden Kapselhalterteile des mittleren Elementes mit Anschlagmuffen nebst je einem inneren Anschlag, von welchen jeder in der Ruhestellung mit einem Anschlag des jeweiligen Perforiernadelhalterelementes in Anlage zu bringen ist, verbunden sind, vorzugsweise durch Verkleben beziehungsweise Reibungsverriegelung, und in der Arbeitsstellung beziehungsweise beim Durchstoßen der Kapsel der Anschlag des jeweiligen Perforiernidelhalterelementes mit dem jeweiligen Kapselhalterteil in Anlage zu bringen ist.According to one embodiment of the inventive concept, it is expedient that the two capsule holder parts of the middle Element with stop sleeves plus one inner stop each, each of which in the rest position with a stop of the respective perforating needle holder element in Is to bring plant, are connected, preferably by gluing or friction locking, and in the Working position or the stop of the respective perforating pin holder element when the capsule is pierced is to be brought into contact with the respective capsule holder part.

7411543 Q5.02J67411543 Q5.02J6

Eej ist auch gemäß einer weiteren Ausgestaltung vorteilhaft, daß die Roibun^sVerriogelung der Perforiorcad 1-halterelcsento mit dera oberen Clement beziehungsweise dem iliiaehluiostück des unteren üloLientoo für die Pu.ipc üox-jio die Kupplun^sverriegelung der Anschlagmuffon. mit den Kapse1 haltorteilen durch Hilcporippen mit Öägezühnen gebildetEej is also advantageous according to a further embodiment, that the Roibun ^ sVerriogelung the Perforiorcad 1-halterelcsento with dera upper Clement respectively the iliiaehluio piece of the lower üloLientoo for the Pu.ipc üox-jio the coupling lock of the stop muffon. with the caps 1 holder parts formed by Hilcporippen with Öägezhnen

Vorzucstireise ist das untere Element des Inhalators von solcher Porin, daß bei ITichtp.etorauch der Inhalatorkorper innerhalb der Pumpe lamgekehrt» zweckmäßigerw iao bei aurrechter Stellung der Purape nach unton, eingesetzt v/erdcn kann, wodurch eine beträchtliche Verrincei-uns des PlatKbodarfcs nebst Steigerung der Gebrauchsfähi^keit und ein gefällico^ kompaktes Aussehen des Gerätes erreicht werden.Pre-travel is the lower element of the inhaler from such a porin that at ITichtp.etorauch the inhalator body is within the pump turned upside down »more expediently w iao with aurgere Position of the Purape towards Unton, can be inserted, thereby making a considerable verrincei-us des PlatKbodarfcs in addition to an increase in usability and a pleasing quality compact appearance of the device can be achieved.

Nach einer besonders vorteilhaften Ausführungsforn der Er findung ist daher das Profil der zylindrischen Oberfläche dos unteren Teiles des Inhalators glatt beziehungsweise poliert und gleichförmig und von einem Vorsprung, an welchen das Mund stück der Pumpe durch Reibungsverriogolung in Anlage su bringen ist, unterbrochen. Dabei sind vorzugsweice die Berührung stellen der zylindrischen Oberfläche des unteren Teiles des Inhalator^ mit der geraden Oberfläche des Vorsprunges Verriegelungsstellen zur Reibungsverriegelung mit der Pumpe im gebrauchsbereiten Zustand des Inhalators. Auch sind vorzugsweise die Berührunjsstellen der zylindrischen Oberfläche des unteren Teiles des Inhalators mit der gekrümmten Oberfläche des V.orsprung^s Verriegelungsstellcn zur Reibungsverriegeluug mit der Punpe im Ruhezustand des Inhalators.According to a particularly advantageous embodiment of the Er finding is therefore the profile of the cylindrical surface dos lower part of the inhaler smooth or polished and uniform and of a protrusion on which the mouth part of the pump is brought into the system by frictional locking, interrupted. Touch is preferred make the cylindrical surface of the lower part of the inhaler ^ locking points with the straight surface of the projection for frictional locking with the pump when the inhaler is ready for use. Also are preferred the contact points of the cylindrical surface of the lower part of the inhaler with the curved surface of the protrusion of the locking position for friction locking with the pump while the inhaler is at rest.

Der erfindungsgemäße Inhalator wird an Hand des folgenden Ausführungsbeispieles in Verbindung mit den beiliegenden Zeichnungen näher erläutert.The inhaler of the present invention is illustrated by the following Embodiment explained in more detail in connection with the accompanying drawings.

7411543 05.02.767411543 02/05/76

_ 4- —
Hierbei sind:
_ 4- -
Here are:

Figur 1 ein Lü;i;;cschnitt durch einen erfindun;;s~ graiißon Inhalator in GruMctellui'^ beziehungsweise vor Ingebrauchnahme,Figure 1 a Lü; i ;; c section through an invention ;; s ~ gray inhaler in GruMctellui '^ respectively before use,

Figur 2 oin Schnitt längs der Linie II II vonFigure 2 o in section along the line II II of

Figur 1,Figure 1,

Figur 3 ein in Figur 1 enthaltener Kupplungsteil des erfindungGgemäßen Inhalators in demgegenüber vergrößerter Darrteilung undFIG. 3 shows a coupling part of the inhaler according to the invention contained in FIG. 1 in contrast enlarged presentation and

Figur 4 der Inhalator vor Figur 1 nach Ingebrauchnahme beziehungsweise nach den Durchstoßen einer darin enthaltenen Kapsel»FIG. 4 shows the inhaler in front of FIG. 1 after it has been used or after piercing a capsule contained therein »

Gemäß den Figuren 1 und 4- umfaßt der Inhalator ein oberes Element 1, aus welchem ein von einer Kapsel 16 nach dem Durchstoßen verteiltes Pulver zum Ausströmen gebracht wird, und ein Anschlußstück beziehungsweise Mundstück 10 zum Anschließen des Inhalators an eine herkömmliche Pumpe 15« Da die Pumpe 15 eine große Zahl von Ausführungen haben kann, wird sie nicht näher beschrieben und ist nur schematisch dargestellt. In oberen Element 1 beziehungsweise im Anschlußstück 10 sind Perforiernadelh^lterelemente beziehungsweise -anschlußstüclie 2, 2' befestigt, wobei die Verbindung durch Verkleben oder durch Kündelungen 13t deren Profile gemäß Figur 3 eine iieibungsverriegelung bewirken, herbeigeführt wird, wie uus Figur 2 hervorgeht, ist die Perforiernadel 5 beziehungsweise 51 in dos Porforiornadelhultcrolcment 2 beziehungsweise 2' hineingeschoben und wird durch vier radiale Rippen 9 beziehungsweise 91» welche neben dem Halten der Perforiernadel 5 beziehungsweise 5* den Durchgang von Luft gestatten, gehalten.According to FIGS. 1 and 4, the inhaler comprises an upper element 1, from which a powder distributed by a capsule 16 after being pierced is made to flow out, and a connector or mouthpiece 10 for connecting the inhaler to a conventional pump 15 Pump 15 can have a large number of designs, it is not described in detail and is only shown schematically. Perforiernadelh ^ lterelemente or -anschlussstüclie 2, 2 'are attached in the upper element 1 or in the connection piece 10, the connection being brought about by gluing or by means of bundles 13t whose profiles according to FIG Perforating needle 5 or 5 1 is pushed into dos Porforiornadelhultcrolcment 2 or 2 'and is held by four radial ribs 9 or 9 1 ' which, in addition to holding the perforating needle 5 or 5 *, allow air to pass through.

7411543 05.02.767411543 02/05/76

trittsöffnung für die Arzneimittel sub stanz und 22 der Einlaß für die durch die Pumpe 15 gepumpte Luft·opening for the drug substance and 22 the inlet for the air pumped by the pump 15

AOAO

Die Rippen 9» 91 legen sowohl Luftdurchgänge fest als auch verbinden sie die Perforiernadelhalterung mit dem Körper des betreffenden Perforiernadelhalterelementes 2 beziehungsweise 2'.The ribs 9 »9 1 both define air passages and connect the perforating needle holder to the body of the relevant perforating needle holder element 2 or 2 '.

In Figur 1 sind die inneren Anschläge 20, 20' der Anschlagmuffen 7» 71 in Anlage mit den Anschlägen 19» 19' der Perforiernadelhalterelemente 2, 21 gezeigt, während sich in Figur 2 die Anschläge 19* 19' der Perforiernadelhalterelemente 2, 21 mit den rohrförmigen Verlängerungen 6, 61 der Kapselhalterelemente J, 4 in Anlage befinden.In Figure 1, the internal stops 20, 20 'of the stop sleeves 7 »7 1 into abutment with the stops 19' 19 'of the Perforiernadelhalterelemente 2 shown 2 1, while in Figure 2, the stops 19 * 19' of the Perforiernadelhalterelemente 2, 2 1 are in contact with the tubular extensions 6, 6 1 of the capsule holder elements J, 4.

In den Figuren 1 und 4 ist das Profil der zylindrischen Oberfläcne des unteren Teiles 10 des Inhalatorkörpers, welcher durch Reibungsverriegelung mit der Pumpe 15 von geeigneten Abmessungen verbunden ist, glatt beziehungsweise poliert und gleichförmig und von einem Vorsprung 11, dessen Berührungsstellen 12, 12' mit der zylindrischen Oberfläche des unteren Teiles 10 des Inhalatorkörpers die Anschlagstellen zur Reibungsverriegelung mit der Pumpe 15 darstellen, wenn der Inhalator gebrauchsbereit ist beziehungsweise nicht gebraucht wird, unterbrochen.In Figures 1 and 4, the profile is the cylindrical Surface of the lower part 10 of the inhaler body, which by frictional locking with the pump 15 of suitable Dimensions is connected, smooth or polished and uniform and by a projection 11, the points of contact 12, 12 'with the cylindrical surface of the lower Part 10 of the inhaler body represent the stop points for frictional locking with the pump 15 when the inhaler is ready for use or is not used, interrupted.

Die Arbeitsweise des Inhalators ist wie folgt:The way the inhaler works is as follows:

Zunächst wird der innerhalb der Pumpe 1.5 umgekehrt, zweckmäßigerweise bei aufrechter Stellung der Pumpe 15 nach unten, angeordnete Inhalatorkörper von der letzteren entfernt und innerhalb derselben durch Reibungsverriegelung in seiner mit der Pompe 15 gleichsinnigen Anordnung, zweckmäßigerweise in aufrechter Stellung bei aufrechter Stellung der Pumpe 15, mit der Pumpe 15 verbundene Dann wird der Kapselhalterteil 4First, the inside of the pump 1.5 is reversed, expediently with the pump 15 in an upright position below, located inhaler body removed from the latter and within the same by friction locking in its with the Pompe 15 arrangement in the same direction, expediently in the upright position with the upright position of the pump 15, connected to the pump 15 Then the capsule holder part 4

— 1 —- 1 -

7411543 05.01767411543 05.0176

vom Kapselhalterteil 3 abgeschraubt und die Kapsel 16 eingesetzt, worauf das obere Element 1 und das Anschlußstück 10 des unteren Teiles gegeneinanderbewegt werden, das heißt eine Verkürzung beziehungsweise Stauchung des Inhalators längs der Pfeile A und B hervorgerufen wird, was zu zwei diametral entgegengesetzten Einstichen in die Kapsel 16 führt. Daher genügt es, die Pumpe 15 zu drücken, um den pulverförmigen Inhalt der Kapsel 16 in einsn Hohlraum von Mensch oder Tier, wie Nasenhöhlen beziehungsweise andere Hohlräume des menschlichen oder tierischen Körpers, einzuführen.unscrewed from the capsule holder part 3 and inserted the capsule 16, whereupon the upper element 1 and the connecting piece 10 of the lower part are moved towards one another, that is to say one Shortening or compression of the inhaler along the arrows A and B is brought about, resulting in two diametricals opposite punctures in the capsule 16 leads. It is therefore sufficient to press the pump 15 to dispense the powdery content the capsule 16 in a cavity of humans or animals, such as nasal cavities or other cavities of the human or animal body.

Aus dem Obigen geht die große Vereinfachung, welche durch den erfindungsgemäßen Inhalator mit sehr wenigen Teilen erreicht wurde, weswegen der Zusammenbau nur mit sehr geringen Kosten verbunden ist, hervor.From the above goes the great simplification, which was achieved by the inhaler according to the invention with very few parts, which is why the assembly only with very low cost.

/11/ 11

SchutzansprücheProtection claims

7411543 05.01767411543 05.0176

Claims (6)

1») Inhalator für in einer mittels einer Perforiernadel zu durchstoßenden Kapsel enthaltene pulverförmige Substanzen, welche mit Hilfe einer Pumpe zu verteilen sind, mit einem oberen Teil, an dessen Ende die pulverförmige Substanz austritt, einem mittleren Teil und einem unteren Teil zum Anschließen an di© Pumpe, gekennzeichnet durch ein ortsfestes mittleres Element (3, 4) als mittleren Teil, das von zwei, vorzugsweise durch Verschrauben beziehungsweise eine Bajonettkupplung, miteinander zu verbindenden (17) Kapseihalterteilen (3, 4) gebildet ist und einen Hohlraum (8) zur Aufnahme der Kapsel (16) aufweist, und zwei gegeneinander bewegliche Perforiernadelhalterelemente (2, 21) im oberen Teil (1) beziehungsweise unteren Teil (10), welche in die beiden Kappelhalterteile (3» 4) gegen die Wirkung von Rückholfedern (21, 21·) teleskopartig hineinbewegbar sind.1 ») Inhaler for powdery substances contained in a capsule to be pierced by means of a perforating needle, which are to be distributed with the aid of a pump, with an upper part, at the end of which the powdery substance emerges, a middle part and a lower part for connection to di © Pump, characterized by a stationary central element (3, 4) as the central part, which is formed by two (17) capsule holder parts (3, 4) to be connected to one another, preferably by screwing or a bayonet coupling, and a cavity (8) for Has receptacle of the capsule (16), and two perforating needle holder elements (2, 2 1 ) which can be moved relative to one another in the upper part (1) and lower part (10), which are inserted into the two cap holder parts (3 »4) against the action of return springs (21, 21 ·) can be moved in telescopically. 2.) Inhalator nach Anspruch 1, dadurch gekennzeichnet, daß die beiden Kapselhalterteile (3, 4) des mittleren Elementes (3, 4) mit Anschlagmuffen (7, 7') nebst je einem inneren Anschlag (20, 2O')j von welchen jeder on dar Ruhe stellung mit einem Anschlag (191 19') des jeweiligen Perforiernadelhalterelementes (2, 21) in Anlage zu bringen ist, verbunden sind, vorzugsweise durch Verkleben beziehungsweise Reibungsverriegelung, und in der Arbeitsstellung beziehungsweise beim Durchstoßen der Kapsel (16) der Anschlag (19>Ί9θ des jeweiligen Perforiernadelhalterelementes (2, 21) mit dem jeweiligen Kapselhalterteil (3 oder 4) in Anlage zu "bringen ist«2.) Inhaler according to claim 1, characterized in that the two capsule holder parts (3, 4) of the middle element (3, 4) with stop sleeves (7, 7 ') each together with an inner stop (20, 2O') j of which each on represents rest position with a stop (191 19 ') of the respective perforating needle holder element (2, 2 1 ) to be brought into abutment, are connected, preferably by gluing or friction locking, and in the working position or when the capsule (16) is pierced The stop (19> Ί9θ of the respective perforating needle holder element (2, 2 1 ) is to be brought into contact with the respective capsule holder part (3 or 4) 7411543 05.02.767411543 02/05/76 t ·t 3.) Inhalator nach Anspruch 1 oder 2, dadurch gekennzeichnet, daß die Reibungsverriegelung der Perforiernadelhalterelemente (2, 21) mit dem oberen Element (1) beziehungsweise dem AnSchlußstück (10) des unteren Elementes für die Pumpe (15) sowie die Kupplungsverrl?gelung der Ansehlagmuffen (7f 7') mit den Kapselhalterteilen (3, 4) durch Mikrorippen (9, 91) mit Sägre zahnen gebildet wird.3.) Inhaler according to claim 1 or 2, characterized in that the friction locking of the perforating needle holder elements (2, 2 1 ) with the upper element (1) or the connecting piece (10) of the lower element for the pump (15) and the clutch lock? gelation of the Ansehlagmuffen (7 f 7 ') with the capsule holder parts (3, 4) is formed by micro-ribs (9, 9 1 ) with saw teeth. 4.) Inhalator nach Anspruch 1 bis 3» dadurch gekennzeichnet, daß das Profil der zylindrischen Oberfläche seines unteren Teiles (10) glatt beziehungsweise poliert und gleichförmig ist und von einem Vorsprung (11), an welchen das Mundstück der Pumpe (15) durch Reibungsverriegelung in Anlage zu bringen ist, unterbrochen ist.4.) Inhaler according to claim 1 to 3 »characterized in that that the profile of the cylindrical surface of its lower part (10) is smooth or polished and is uniform and of a projection (11) on which the mouthpiece of the pump (15) passes Friction lock is to be brought into contact is interrupted. 5·) Inhalator nach Anspruch 1 bis 4, dadurch gekennzeichnet, daß die Berührungsstellen (12) der zylindrischen Oberfläche seines unteren Teiles (10) mit der geraden Oberfläche des Vorsprunges (11) Verriegelungsstellen zur Reibungsverriegelung mit der Pumpe (15) im gebrauchsbereiten Zustand des Inhalators sind.5.) Inhaler according to claim 1 to 4, characterized in that that the points of contact (12) of the cylindrical surface of its lower part (10) with the straight Surface of the projection (11) locking points for friction locking with the pump (15) ready for use Condition of the inhaler. 6.) Inhalator nach Anspruch Ibis 4, dadurch gekennzeichnet, daß die Berührungssreilen (12') der zylindrischen Oberfläche seines unteren Teiles (10) mit der gekrümmten Oberfläche des Vorsprunges (11) Verriegelungsstellen zur Reibungsverriegelung mit der Pumpe (15) im Ruhezustand des Inhalators sind.6.) Inhaler according to claim Ibis 4, characterized in that that the contact ropes (12 ') of the cylindrical Surface of its lower part (10) with the curved surface of the projection (11) locking points for frictional locking with the pump (15) when the inhaler is at rest. 7411543 05.01767411543 05.0176
DE7411543U 1973-04-04 1974-04-02 INHALER FOR POWDERED SUBSTANCES Expired DE7411543U (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2257673A IT986056B (en) 1973-04-04 1973-04-04 INSUFFLATOR FOR POWDER-SHAPED MEDICATIONS
IT2569873A IT1045851B (en) 1973-06-22 1973-06-22 Inhaler for administering powdered medicaments - offers long term trouble free efficiency from particularly simple, inexpensive construction

Publications (1)

Publication Number Publication Date
DE7411543U true DE7411543U (en) 1976-02-05

Family

ID=26328226

Family Applications (2)

Application Number Title Priority Date Filing Date
DE7411543U Expired DE7411543U (en) 1973-04-04 1974-04-02 INHALER FOR POWDERED SUBSTANCES
DE2415961A Pending DE2415961A1 (en) 1973-04-04 1974-04-02 INHALER FOR POWDERED SUBSTANCES

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2415961A Pending DE2415961A1 (en) 1973-04-04 1974-04-02 INHALER FOR POWDERED SUBSTANCES

Country Status (7)

Country Link
US (1) US3906950A (en)
JP (1) JPS5048782A (en)
BE (1) BE813143A (en)
CH (1) CH569486A5 (en)
DE (2) DE7411543U (en)
FR (1) FR2224175B1 (en)
GB (1) GB1436813A (en)

Families Citing this family (212)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (en) * 1974-07-15 1977-07-20 Isf Spa APPARATUS FOR INHALATIONS
YU41046B (en) * 1974-08-22 1986-10-31 Schering Ag Medicine inholating device
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
GB1562732A (en) * 1976-02-10 1980-03-12 Allen & Hanburys Ltd Device for dispensing medicaments
US4095596A (en) * 1976-11-26 1978-06-20 Smithkline Corporation Nasal inhaler
IT1116047B (en) * 1979-04-27 1986-02-10 Sigma Tau Ind Farmaceuti DEVICE FOR THE QUICK INHALATION OF POWDER DRUGS BY PERSONS SUFFERING FROM ASTHMA
JPS57500862A (en) * 1979-10-30 1982-05-20
DE3345722A1 (en) * 1983-12-17 1985-06-27 Boehringer Ingelheim KG, 6507 Ingelheim INHALATOR
US4620847A (en) * 1984-06-01 1986-11-04 Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov Device for administering powdered substances
US4645487A (en) * 1984-06-05 1987-02-24 Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov Device for administering powdered substances
IT1222509B (en) * 1987-08-17 1990-09-05 Miat Spa INSUFFLATOR FOR THE ADMINISTRATION OF DRUGS IN THE FORM OF PRE-DOSED POWDER IN OPERATIONS
IT1228460B (en) * 1989-02-23 1991-06-19 Phidea S R L DISPOSABLE INHALER WITH PRE-PERFORATED CAPSULE
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
IT1237118B (en) * 1989-10-27 1993-05-18 Miat Spa MULTI-DOSE INHALER FOR POWDER DRUGS.
DE4027391A1 (en) * 1990-08-30 1992-03-12 Boehringer Ingelheim Kg GAS-FREE INHALATION DEVICE
US6540154B1 (en) 1991-04-24 2003-04-01 Aerogen, Inc. Systems and methods for controlling fluid feed to an aerosol generator
US7628339B2 (en) 1991-04-24 2009-12-08 Novartis Pharma Ag Systems and methods for controlling fluid feed to an aerosol generator
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
DE4128295A1 (en) * 1991-08-27 1993-03-04 Pfeiffer Erich Gmbh & Co Kg DISCHARGE DEVICE FOR FLOWABLE MEDIA
DK198591D0 (en) * 1991-12-10 1991-12-10 Novo Nordisk As APPARATUS
HU216405B (en) * 1993-03-03 1999-06-28 Tenax Corp. Dry powder inhalator medicament carrier
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5488946A (en) * 1994-03-01 1996-02-06 Calhoun; Clifford A. Emergency breathing device for opening cartridges
JP3372105B2 (en) * 1994-05-26 2003-01-27 株式会社日立ユニシアオートモティブ Inhalation type dispenser
CA2199417C (en) * 1994-10-24 2008-07-08 Brian John Bellhouse Particle delivery
US5901703A (en) * 1995-02-06 1999-05-11 Unisia Jecs Corporation Medicine administering device for nasal cavities
JP3308425B2 (en) * 1995-03-10 2002-07-29 株式会社ユニシアジェックス Nasal administration device
US6085740A (en) 1996-02-21 2000-07-11 Aerogen, Inc. Liquid dispensing apparatus and methods
US5758637A (en) * 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
US6209538B1 (en) 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5692496A (en) * 1995-08-02 1997-12-02 Innovative Devices, Llc Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5823183A (en) * 1995-08-02 1998-10-20 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5988163A (en) * 1995-08-02 1999-11-23 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
DE19533979A1 (en) * 1995-09-14 1997-03-20 Alfred Von Schuckmann Device for the dosed, airborne delivery of substances
JP3317827B2 (en) * 1995-10-09 2002-08-26 株式会社ユニシアジェックス Dosing device
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
JP3328132B2 (en) * 1996-03-21 2002-09-24 株式会社ユニシアジェックス Inhaler type dispenser
AUPN976496A0 (en) * 1996-05-10 1996-05-30 Glaxo Wellcome Australia Ltd Unit dose dispensing device
EP0991443A1 (en) * 1997-06-23 2000-04-12 Marco Cecchini Inhaling device
JP3488620B2 (en) * 1998-02-05 2004-01-19 株式会社日立ユニシアオートモティブ Inhalation type dispenser
JP3530004B2 (en) * 1998-02-06 2004-05-24 株式会社日立ユニシアオートモティブ Inhalation type dispenser
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
US7112341B1 (en) 1999-04-13 2006-09-26 Nektar Therapeutics Pulmonary administration of dry powder formulations for treating infertility
US9006175B2 (en) * 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2001000654A2 (en) * 1999-06-29 2001-01-04 Pharmaceutical Discovery Corporation Purification and stabilization of peptide and proteins in pharmaceutical agents
US7464706B2 (en) * 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US7305986B1 (en) 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
US6235177B1 (en) 1999-09-09 2001-05-22 Aerogen, Inc. Method for the construction of an aperture plate for dispensing liquid droplets
HU229310B1 (en) * 1999-10-29 2013-10-28 Nektar Therapeutics Dry powder compositions having improved dispersivity
DE19960459A1 (en) * 1999-12-15 2001-06-21 Pfeiffer Erich Gmbh & Co Kg Media Donor
US20010029947A1 (en) * 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US6968840B2 (en) 2000-05-05 2005-11-29 Aerogen, Inc. Methods and systems for operating an aerosol generator
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US7600511B2 (en) 2001-11-01 2009-10-13 Novartis Pharma Ag Apparatus and methods for delivery of medicament to a respiratory system
MXPA02010884A (en) 2000-05-05 2003-03-27 Aerogen Ireland Ltd Apparatus and methods for the delivery of medicaments to the respiratory system.
US6948491B2 (en) 2001-03-20 2005-09-27 Aerogen, Inc. Convertible fluid feed system with comformable reservoir and methods
US7100600B2 (en) 2001-03-20 2006-09-05 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US6948494B1 (en) 2000-05-10 2005-09-27 Innovative Devices, Llc. Medicament container with same side airflow inlet and outlet and method of use
AU2001283546A1 (en) 2000-08-14 2002-02-25 Advanced Inhalation Research, Inc. Inhalation device and method
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6732944B2 (en) 2001-05-02 2004-05-11 Aerogen, Inc. Base isolated nebulizing device and methods
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
GB2380410B (en) * 2001-10-05 2003-11-19 Alchemy Healthcare Ltd Apparatus for the nasal or oral delivery of a medicament
MXPA04004631A (en) * 2001-11-14 2004-08-12 Nektar Therapeutics Al Corp Aerosolization apparatus comprising connectable body and endpiece.
US7368102B2 (en) * 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7677467B2 (en) 2002-01-07 2010-03-16 Novartis Pharma Ag Methods and devices for aerosolizing medicament
AU2003202925B2 (en) 2002-01-07 2008-12-18 Aerogen, Inc. Devices and methods for nebulizing fluids for inhalation
ITMI20020078A1 (en) * 2002-01-16 2003-07-16 Fabrizio Niccolai DEVICE USABLE IN THE TREATMENT OF RESPIRATORY TRACT AFFECTIONS
DE60318938T2 (en) 2002-03-20 2009-01-22 Mannkind Corp., Valencia INHALER
JP3950738B2 (en) * 2002-05-14 2007-08-01 株式会社 バイオアクティス Nasal powder medicine administration device
WO2003097126A2 (en) 2002-05-20 2003-11-27 Aerogen, Inc. Aerosol for medical treatment and methods
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
CN1758930B (en) 2003-03-27 2010-06-09 株式会社新日本科学 Powder medicine applicator for nasal cavity
MXPA05010842A (en) 2003-04-09 2006-03-30 Nektar Therapeutics Aerosolization apparatus with air inlet shield.
US8869794B1 (en) * 2003-04-09 2014-10-28 Novartis Pharma Ag Aerosolization apparatus with capsule puncturing member
US8616195B2 (en) 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication
US7338171B2 (en) * 2003-10-27 2008-03-04 Jen-Chuen Hsieh Method and apparatus for visual drive control
CN101027082A (en) * 2004-01-12 2007-08-29 曼恩坎德公司 Method of reducing serum proinsulin levels in type 2 diabetics
JP2007522246A (en) * 2004-02-12 2007-08-09 ネクター セラピューティクス Interleukin-13 antagonist powder, spray-dried particles, and method
US20080248999A1 (en) * 2007-04-04 2008-10-09 Biodel Inc. Amylin formulations
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
US7290541B2 (en) 2004-04-20 2007-11-06 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7267121B2 (en) 2004-04-20 2007-09-11 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7946291B2 (en) 2004-04-20 2011-05-24 Novartis Ag Ventilation systems and methods employing aerosol generators
CN1946453A (en) * 2004-04-23 2007-04-11 米斯提克医药有限公司 Multiple unit dose drug delivery system
US7611709B2 (en) * 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US7723306B2 (en) * 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US7727962B2 (en) * 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
JP2008503500A (en) 2004-06-18 2008-02-07 ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド Treatment of bronchial infections
EP1785145A4 (en) 2004-08-10 2008-08-13 Translational Res Ltd Transnasal composition having immediate action and high absorbability
EP1786784B1 (en) 2004-08-20 2010-10-27 MannKind Corporation Catalysis of diketopiperazine synthesis
CA2578175C (en) 2004-08-23 2014-10-14 Mannkind Corporation Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
GB0420513D0 (en) * 2004-09-15 2004-10-20 Optinose As Powder delivery devices
BRPI0516701B1 (en) 2004-11-10 2017-11-28 Cipla Ltd. INHALER DEVICE FOR INHALATION OF A MEDICATION OF A PERFORABLE CAPSULE
PT1901749T (en) 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7614429B2 (en) * 2005-05-18 2009-11-10 Symyx Solutions, Inc. Apparatus and methods for storing and dispensing solid material
MX2007014867A (en) 2005-05-25 2008-02-21 Aerogen Inc Vibration systems and methods.
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
US8084420B2 (en) * 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
WO2007041481A1 (en) * 2005-09-29 2007-04-12 Biodel, Inc. Rapid acting and prolonged acting insulin preparations
BRPI0707991B8 (en) 2006-02-22 2021-05-25 Mannkind Corp methods of preparing a dry powder medicine with an improved pharmaceutical property, said dry powder and using an effective amount of the dry powder
DE102006010089A1 (en) 2006-02-24 2007-10-18 Aha-Kunststofftechnik Gmbh The dry powder inhaler
CA2649109A1 (en) * 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
EP1844805A1 (en) * 2006-04-13 2007-10-17 Boehringer Ingelheim Pharma GmbH & Co.KG Inhaler
US7806117B2 (en) * 2006-06-07 2010-10-05 Shin Nippon Biomedical Laboratories, Ltd. Peroral powder delivery device
UY30418A1 (en) * 2006-06-16 2008-01-31 Cipla Ltd IMPROVED DRY POWDER INHALER
EP2116264B1 (en) 2006-12-26 2017-09-27 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
CA2886385A1 (en) * 2007-01-09 2008-07-17 Mystic Pharmaceuticals, Inc. Intranasal cartridge devices
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
US8683995B2 (en) 2007-05-16 2014-04-01 Mystic Pharmaceuticals, Inc. Dose dispensing containers
CN105776119B (en) 2007-05-16 2019-04-23 神秘制药公司 Combination unit dose dispensing containers
US9248076B2 (en) 2007-05-16 2016-02-02 Mystic Pharmaceuticals, Inc. Dose dispensing containers
US8496002B2 (en) * 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
EP2020249A1 (en) * 2007-08-01 2009-02-04 Boehringer Ingelheim Pharma GmbH & Co. KG Inhalator
CA2886525A1 (en) * 2007-09-14 2009-03-19 Mystic Pharmaceuticals, Inc. Deep draw container forming method
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
JP5350388B2 (en) * 2007-10-25 2013-11-27 ノバルティス アーゲー Powder preparation of unit dose drug package
AU2009204309B2 (en) * 2008-01-04 2012-11-22 Biodel, Inc. Insulin formulations for insulin release as a function of tissue glucose levels
SI2082769T1 (en) 2008-01-24 2015-10-30 Vectura Delivery Devices Limited Inhaler
CN101980738A (en) 2008-02-07 2011-02-23 华盛顿大学 Circumferential aerosol device
CN101980743B (en) * 2008-03-27 2014-04-02 曼金德公司 A dry powder inhalation system
EP2570147B1 (en) 2008-06-13 2017-10-18 MannKind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
TWI614024B (en) 2008-08-11 2018-02-11 曼凱公司 Use of ultrarapid acting insulin
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US20110171312A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Modified therapeutic peptides, methods of their preparation and use
PL2344129T3 (en) 2008-10-07 2018-07-31 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
JP2012505222A (en) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド Inhalation of levofloxacin to reduce lung inflammation
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
PL2405963T3 (en) 2009-03-11 2014-04-30 Mannkind Corp Apparatus, system and method for measuring resistance of an inhaler
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
KR20180079458A (en) 2009-06-12 2018-07-10 맨카인드 코포레이션 Diketopiperazine microparticles with defined specific surface areas
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
ES2739979T3 (en) 2009-09-04 2020-02-05 Horizon Orphan Llc Use of levofloxacin spray for the treatment of cystic fibrosis
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
CA2779488A1 (en) 2009-11-12 2011-05-19 Stc.Unm Dry powder inhaler with flutter dispersion member
RU2531455C2 (en) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Systems and methods for dry powder drugs delivery
EP3012258B1 (en) 2010-06-24 2018-09-19 Gilead Sciences, Inc. Pharmaceutical composition comprising a pyrazolo[1,5-a]pyrimidine derivative as an antiviral agent
PL2595980T3 (en) 2010-07-22 2015-03-31 Gilead Sciences Inc Methods and compounds for treating paramyxoviridae virus infections
TW201305185A (en) 2010-09-13 2013-02-01 Gilead Sciences Inc 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
ES2646748T3 (en) 2010-12-07 2017-12-15 Respira Therapeutics, Inc. Dry powder inhaler
DK2670242T3 (en) 2011-01-31 2022-05-02 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof
CN103917265B (en) 2011-03-03 2017-02-15 英倍尔药业股份有限公司 Nasal drug delivery device
CN105667994B (en) 2011-04-01 2018-04-06 曼金德公司 Blister package for pharmaceutical kit
JP6645735B2 (en) 2011-05-09 2020-02-14 インペル ニューロファーマ インコーポレイテッド Nose delivery nozzle
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
WO2013016784A1 (en) 2011-08-04 2013-02-07 Victor Esteve Dry powder inhaler
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
US10463815B2 (en) 2012-02-21 2019-11-05 Respira Therapeutics, Inc. Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
EP2834258B1 (en) * 2012-03-13 2017-01-04 Gilead Sciences, Inc. 2'- substituted carba-nucleoside analogs for antiviral treatment
JP2015516976A (en) 2012-04-17 2015-06-18 ギリアード サイエンシーズ, インコーポレイテッド Compounds and methods for antiviral treatment
WO2013184951A2 (en) * 2012-06-06 2013-12-12 Aerodesigns, Inc. Aerosol dispenser with replaceable cartridge
CN108057154B (en) 2012-07-12 2021-04-16 曼金德公司 Dry powder drug delivery system and method
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
CA2906817C (en) 2013-03-15 2022-01-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
EP2991713B1 (en) 2013-04-28 2019-06-19 Impel Neuropharma Inc. Medical unit dose container
EP3607941A1 (en) 2013-04-30 2020-02-12 Otitopic Inc. Dry powder formulations and methods of use
WO2015006639A1 (en) 2013-07-12 2015-01-15 SILVA, John, H. Mouthpiece for inhalers
BR112015031590B1 (en) 2013-07-16 2021-05-18 Victor Esteve powder inhaler
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
CA3172586A1 (en) 2013-07-31 2015-02-05 Avalyn Pharma Inc. Aerosol imatininb compounds and uses thereof
JP2016530930A (en) 2013-08-05 2016-10-06 マンカインド コーポレイション Ventilation device and method
UA119050C2 (en) 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. Pyrrolo [1,2,f] [1,2,4] triazines useful for treating respiratory syncitial virus infections
EP3091976A4 (en) 2014-01-10 2017-10-11 Genoa Pharmaceuticals Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
PL3107548T3 (en) 2014-02-20 2022-10-31 Otitopic Inc. Dry powder formulations for inhalation
USD752734S1 (en) 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
USD752204S1 (en) 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler
USD755367S1 (en) 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
USD748242S1 (en) 2014-07-11 2016-01-26 H. Stuart Campbell Inhaler mouthpiece
TWI678369B (en) 2014-07-28 2019-12-01 美商基利科學股份有限公司 Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines useful for treating respiratory syncitial virus infections
TWI673283B (en) 2014-08-21 2019-10-01 美商基利科學股份有限公司 2'-chloro aminopyrimidinone and pyrimidine dione nucleosides
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
JP2018501903A (en) 2015-01-14 2018-01-25 レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. Powder dispersion method and apparatus
US10874139B2 (en) * 2015-07-07 2020-12-29 Altria Client Services Llc E-vapor device including capsule containing pre-vapor formulation
WO2017044897A1 (en) 2015-09-10 2017-03-16 Impel Neuropharma Inc. In-line nasal delivery device
US10940274B2 (en) 2015-12-01 2021-03-09 Cipla Limited Nasal spray assembly
JP6976970B2 (en) * 2016-07-07 2021-12-08 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Nicotine inhaler system
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
FR3072313B1 (en) * 2017-10-12 2019-10-11 Aptar France Sas DEVICE FOR DISPENSING FLUID PRODUCT
CA3081680A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
US11571532B2 (en) 2017-11-21 2023-02-07 Impel Pharmaceuticals Inc. Intranasal device with dip tube
KR20200118032A (en) 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 Intranasal delivery of dihydroergotamine by precise olfactory organ device
CA3087698A1 (en) 2018-01-05 2019-07-11 Impel Neuropharma, Inc. Intranasal delivery of olanzapine by precision olfactory device
WO2020018959A1 (en) 2018-07-19 2020-01-23 Impel Neuropharma, Inc. Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease
CN109078245A (en) * 2018-10-11 2018-12-25 上海博极给药医药科技有限公司 A kind of double-capsule type powder inhaler
CN113473967B (en) 2019-01-03 2022-09-09 英倍尔制药公司 Transnasal drug delivery device
EP3969085A4 (en) 2019-05-17 2023-06-21 Impel Pharmaceuticals Inc. Single-use nasal delivery device
WO2021130638A1 (en) 2019-12-24 2021-07-01 Carna Biosciences, Inc. Diacylglycerol kinase modulating compounds
TWI775313B (en) 2020-02-18 2022-08-21 美商基利科學股份有限公司 Antiviral compounds
TW202322824A (en) 2020-02-18 2023-06-16 美商基利科學股份有限公司 Antiviral compounds
TWI791193B (en) 2020-02-18 2023-02-01 美商基利科學股份有限公司 Antiviral compounds
JP7429799B2 (en) 2020-02-18 2024-02-08 ギリアード サイエンシーズ, インコーポレイテッド antiviral compounds
KR20230006891A (en) 2020-05-01 2023-01-11 길리애드 사이언시즈, 인코포레이티드 2,4-dioxopyrimidine compounds that inhibit CD73
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CA3222277A1 (en) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
EP4359389A1 (en) 2021-06-23 2024-05-01 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
CA3222439A1 (en) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
KR20240005901A (en) 2021-06-23 2024-01-12 길리애드 사이언시즈, 인코포레이티드 Diacylglycerol Kinase Modulating Compounds
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof
WO2023077030A1 (en) 2021-10-29 2023-05-04 Gilead Sciences, Inc. Cd73 compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2307986A (en) * 1940-02-15 1943-01-12 Bolte Insufflator
US2519555A (en) * 1945-08-31 1950-08-22 Abbott Lab Sterile medicament insufflator cartridge and insufflator
US2517482A (en) * 1949-04-09 1950-08-01 Sharp & Dohme Inc Inhaler
US2581182A (en) * 1950-03-14 1952-01-01 Abbott Lab Inhaler
US2946332A (en) * 1957-12-23 1960-07-26 Nysco Lab Inc Insufflator
US3669113A (en) * 1966-03-07 1972-06-13 Fisons Ltd Inhalation device
US3507277A (en) * 1966-09-17 1970-04-21 Fisons Pharmaceuticals Ltd Inhalation device

Also Published As

Publication number Publication date
GB1436813A (en) 1976-05-26
CH569486A5 (en) 1975-11-28
US3906950A (en) 1975-09-23
FR2224175B1 (en) 1978-04-14
JPS5048782A (en) 1975-05-01
BE813143A (en) 1974-07-31
DE2415961A1 (en) 1974-10-17
FR2224175A1 (en) 1974-10-31

Similar Documents

Publication Publication Date Title
DE7411543U (en) INHALER FOR POWDERED SUBSTANCES
DE60216265T2 (en) IMPROVEMENTS IN SPRAY MOUNTS
DE69206988T2 (en) Device for injecting a predetermined dose of a medium and method for filling this device
DE69304320T2 (en) BLOOD DETECTION DEVICE
DE60212764T2 (en) inhaler
EP0827782B1 (en) Fluid dispenser
DE2435186A1 (en) APPLICATION DEVICE FOR POWDERED DRUGS
DE10140704A1 (en) Process for mixing a poorly soluble pharmaceutical substance with a solvent and syringe to apply the process
EP2085147B1 (en) Device with pressure charged piston for dispensing a multiple syringe or multiple cartridge
DE7434592U (en) INHALER FOR POWDERED SUBSTANCES
DE3342407A1 (en) INJECTION DEVICE
DE10011120A1 (en) Media Donor
DE2719815A1 (en) MEDICAL SYRINGE
DE19622124A1 (en) Device for applying liquids
DE2825259C3 (en) Manually operated liquid atomizer
DE3407648A1 (en) CONTAINER FOR APPLICATION OF DENTAL MATERIALS
DE1475172A1 (en) Dosing and non-dosing aerosol spray head
DE10323603A1 (en) Dosing device with a pump device
DE2324296A1 (en) MIXING CONTAINER FOR DENTAL PREPARATIONS
DE8621877U1 (en) Fluid flow regulator for an intravenous delivery device
DE10100359A1 (en) Safety injection syringe and needle holder therefor
DE3803229A1 (en) DISPENSER FOR PORTIONED ISSUE OF PASTOESER MASS
DE102013113791A1 (en) donor
DE8403309U1 (en) Portable, ready-to-use spraying device without cover cap
EP0639389A1 (en) Connector for joining flexible tubing